Gerresheimer AG
General ticker "GRRMF" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $1.4B (TTM average)
Gerresheimer AG does not follow the US Stock Market performance with the rate: -17.7%.
Estimated limits based on current volatility of 2.6%: low 36.09$, high 37.73$
Factors to consider:
- Earnings expected soon, date: 2026-11-04 bmo
Short-term GRRMF quotes
Long-term GRRMF plot
Financial data
| YTD | 2023-11-30 | 2024-11-30 | 2025-11-30 |
|---|---|---|---|
| Operating Revenue | €1,990.49MM | €2,035.90MM | €2,320.89MM |
| Operating Expenses | €1,777.10MM | €1,838.43MM | €2,530.21MM |
| Operating Income | €213.39MM | €197.47MM | €-209.32MM |
| Non-Operating Income | €-45.96MM | €-50.66MM | €-120.81MM |
| Interest Expense | €50.44MM | €60.62MM | €97.74MM |
| R&D Expense | €18.96MM | €22.38MM | €85.89MM |
| Income(Loss) | €167.43MM | €146.81MM | €-330.13MM |
| Taxes | €47.34MM | €34.50MM | €-11.41MM |
| Net Income(Loss)* | €116.13MM | €109.72MM | €-320.32MM |
| Stockholders Equity | €1,445.66MM | €1,511.56MM | €1,081.23MM |
| Assets | €3,429.14MM | €3,809.16MM | €4,493.13MM |
| Operating Cash Flow | €294.34MM | €240.33MM | €209.53MM |
| Capital expenditure | €328.04MM | €369.85MM | €308.32MM |
| Investing Cash Flow | €-307.43MM | €-345.59MM | €-661.77MM |
| Financing Cash Flow | €40.35MM | €168.27MM | €452.97MM |
| Earnings Per Share** | €3.48 | €3.18 | €-9.27 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.